Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Operating Leases (2022)

Sagimet Biosciences' Operating Leases history spans 1 years, with the latest figure at $78000.0 for Q4 2022.

  • Quarterly Operating Leases changed N/A to $78000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $78000.0 through Dec 2022, changed N/A year-over-year, with the annual reading at $78000.0 for FY2022, N/A changed from the prior year.
  • Operating Leases came in at $78000.0 for Q4 2022.
  • In the past five years, Operating Leases ranged from a high of $78000.0 in Q4 2022 to a low of $78000.0 in Q4 2022.